Clinical Application of 2017 McDonald Diagnostic Criteria for Multiple Sclerosis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose McDonald criteria for multiple sclerosis diagnosis have been revised over the years, diagnostic procedures have been simplified and earlier diagnosis facilitated. The new 2017 revision introduces other important changes, with a further simplification for the diagnosis. Oligoclonal bands reassume a more relevant role in the workup. Methods We describe 3 typical cases of patients admitted for clinically isolated syndrome and illustrate how the application of the new criteria can change the diagnostic approach with respect to the previous criteria. Results In two of the three cases a diagnosis of multiple sclerosis is now possible. Conclusions The new 2017 Multiple Sclerosis criteria may have an important impact in clinical practice with an earlier treatment to avoid the risk of disease dissemination. Their application requires a careful assessment to avoid misdiagnosis and mistreatments.
Abstract
Background and Purpose McDonald criteria for multiple sclerosis diagnosis have been revised over the years, diagnostic procedures have been simplified and earlier diagnosis facilitated. The new 2017 revision introduces other important changes, with a further simplification for the diagnosis. Oligoclonal bands reassume a more relevant role in the workup. Methods We describe 3 typical cases of patients admitted for clinically isolated syndrome and illustrate how the application of the new criteria can change the diagnostic approach with respect to the previous criteria. Results In two of the three cases a diagnosis of multiple sclerosis is now possible. Conclusions The new 2017 Multiple Sclerosis criteria may have an important impact in clinical practice with an earlier treatment to avoid the risk of disease dissemination. Their application requires a careful assessment to avoid misdiagnosis and mistreatments.
참고문헌 (20)
- Miller DH, "Clinically isolated syndromes", Lancet Neurol, 11, pp.157~169 (2012)[DOI]
- Brownlee WJ, "Clinically isolated syndromes and the relationship to multiple sclerosis", J Clin Neurosci, 21, pp.2065~2071 (2014)[DOI]
- McDonald WI, "Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis", Ann Neurol, 50, pp.121~127 (2001)[DOI]
- Polman CH, "Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald criteria", Ann Neurol, 58, pp.840~846 (2005)[DOI]
- Polman CH, "Diagnostic criteria for multiple sclerosis: 2010 revisions to the ''McDonald criteria”", Ann Neurol, 69, pp.292~302 (2011)[DOI]
- Thompson AJ, "Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria", Lancet Neurol, 17, pp.162~173 (2018)[DOI]
- Kurtzke JF, "Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)", Neurology, 33, pp.1444~1452 (1983)[DOI]
- Filippi M, "MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines", Lancet Neurol, 15, pp.292~303 (2016)[DOI]
- Caucheteux N, "Criteria improving multiple sclerosis diagnosis at the first MRI", J Neurol, 262, pp.979~987 (2015)[DOI]
- Brownlee WJ, "Should we include lesions in the symptomatic site in dissemination in space in patients with clinically isolated syndromes?", Mult Scler, 23, pp.65~ (2015)
- Tintore M, "Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis", Neurology, 87, pp.1368~1374 (2016)[DOI]
- Tintore M, "Defining high, medium and low impact prognostic factors for developing multiple sclerosis", Brain, 138, pp.1863~1874 (2015)[DOI]
- Kuhle J, "Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study", Mult Scler, 8, pp.1013~1024 (2015)
- Tintore M, "Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?", Neurology, 70, pp.1079~1083 (2008)[DOI]
- Martinelli V, "Multiple biomarkers improve prediction of multiple sclerosis in clinically isolated syndromes", Acta Neurol Scand, 136, pp.454~461 (2017)[DOI]
- Tintore M, "Is optic neuritis more benign than other first attacks in multiple sclerosis?", Ann Neurol, 57, pp.210~215 (2005)[DOI]
- Nolan RC, "Optimal intereye difference thresholds in retinal nerve fiber layer thickness for predicting a unilateral optic nerve lesion in multiple sclerosis", J Neuroophthalmol (2018)
- Bischof A, "Advances in imaging multiple sclerosis", Semin Neurol, 37, pp.538~545 (2017)[DOI]
- Kelly SB, "Using atypical symptoms and red flags to identify non-demyelinating disease", J Neurol Neurosurg Psychiatry, 83, pp.44~48 (2012)[DOI]
- Charil A, "MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation"", Lancet Neurol, 5, pp.841~852 (2006)[DOI]